MRI-based clinical-radiologic model to predict the efficacy and prognosis of interventional with systemic therapy in advanced hepatocellular carcinoma: a multicenter study
MRI imaging combined with clinical data can predict treatment response in advanced liver cancer, informing which patients need surgery or additional therapy.
This multicenter study developed an MRI-based clinical-radiomics model for predicting treatment response and prognosis in advanced HCC receiving combination interventional and systemic therapy, addressing a key clinical decision-making gap in this high-mortality cancer. Multicenter design strengthens generalizability, though abstract was not fully retrieved for detailed performance metrics.
What the study was
- Study design
- Retrospective multicenter imaging study
- Population
- Patients with advanced hepatocellular carcinoma receiving interventional + systemic therapy
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Journal of Translational Medicine
Why it surfaced
Radiomics for HCC treatment response prediction is clinically relevant; multicenter design adds credibility; abstract not retrieved so specific metrics unavailable.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.